Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma M Coomans

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2022
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's diseaseDenise Visser, Sander C J Verfaillie, Emma E Wolters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2025
Correction to: Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2023
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging studyDenise Visser, Sander C J Verfaillie, Iris Bosch, et al.
Brain : a Journal of Neurology|June 6, 2023
Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET studyDeborah N Schoonhoven, Emma M Coomans, Ana P Millán, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2025
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
Brain : a Journal of Neurology|April 20, 2026
Neuropathological correlates of age and sex differences in 18F-flortaucipir PETEmma M Coomans, Ruben Smith, Daria Pawlik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2025
Characterizing visual read tau-PET-negative participants with Alzheimer's disease dementiaRoos M Rikken, Emma M Coomans, Lotte A de Koning, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|January 8, 2022
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's diseaseDenise Visser, Sander C J Verfaillie, Emma E Wolters, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2025
Correction to: Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 28, 2023
Tau pathology as determinant of changes in atrophy and cerebral blood flow: a multi-modal longitudinal imaging studyDenise Visser, Sander C J Verfaillie, Iris Bosch, et al.
Brain : a Journal of Neurology|June 6, 2023
Tau protein spreads through functionally connected neurons in Alzheimer's disease: a combined MEG/PET studyDeborah N Schoonhoven, Emma M Coomans, Ana P Millán, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2020
Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2025
Quantitation of PET spatial extent as a potential adjunct to visual interpretation of [<sup>18</sup>F]flortaucipir imaging: TAU-SPEXEmma M Coomans, Bastiaan van Tol, Colin Groot, et al.
Brain : a Journal of Neurology|April 20, 2026
Neuropathological correlates of age and sex differences in 18F-flortaucipir PETEmma M Coomans, Ruben Smith, Daria Pawlik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2025
Characterizing visual read tau-PET-negative participants with Alzheimer's disease dementiaRoos M Rikken, Emma M Coomans, Lotte A de Koning, et al.
Pageof 4